KOSPI Composite Index Falls 1.19% This Week to 2681.82 — Data Talk
The KOSPI Composite Index is down 32.39 points or 1.19% this week to 2681.82
--Largest one-week percentage decline since the week ending Jan. 19, 2024
--Down for three consecutive weeks
--Down 66.74 points or 2.43% over the last three weeks
--Largest three-week point and percentage decline since the week ending Jan. 26, 2024
--Down four of the past five weeks
--Today it is down 25.14 points or 0.93%
--Largest one-day point and percentage decline since Friday, April 5, 2024
--Down two of the past three trading days
--Off 18.86% from its record close of 3305.21 hit Tuesday, July 6, 2021
--Lowest closing value since Tuesday, March 19, 2024
--Off 2.73% from its 52-week high of 2757.09 hit Tuesday, March 26, 2024
--Up 17.73% from its 52-week low of 2277.99 hit Tuesday, Oct. 31, 2023
--Rose 4.29% from 52 weeks ago
--Off 2.73% from its 2024 closing high of 2757.09 hit Tuesday, March 26, 2024
--Up 10.10% from its 2024 closing low of 2435.90 hit Wednesday, Jan. 17, 2024
--Month-to-date it is down 2.36%
--Year-to-date it is up 26.54 points or 1.00%
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
April 12, 2024 06:44 ET (10:44 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
5 Undervalued Stocks to Buy to Play a Little Defense
-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
After Earnings, Is Tesla Stock a Buy, a Sell, or Fairly Valued?
-
After Earnings, Is GE Aerospace Stock a Buy, a Sell, or Fairly Valued?
-
3 Good Stocks to Buy with Your Tax Refund in 2024 (Or with Any Extra Money)
-
SoFi Earnings: Revenue Growth Slows on Lower Loan Growth and Higher Credit Costs
-
Tesla: Full Self-Driving Approval In China Supports Our View for Deliveries Growth In 2024
-
Philips Earnings: Firm Reaches $1.1 Billion Settlement Agreement
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track